# Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

> **NCT02447341** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 987 (actual)

## Conditions studied

- Anticoagulation, Blood Thinners , Atrial Fibrillation, Bleeding, Stroke

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02447341
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2015-10
- **Final completion:** 2017-01
- **Target enrollment:** 987 (ACTUAL)
- **Last updated:** 2017-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02447341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02447341, "Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02447341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*